Company Data

LAVA Therapeutics N.V.

Ticker
LVTX
Price Target
Refer to Report
Volume
19.4K
52wk Range
$0.8502 - $2
Advanced Market Data

Overview

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy